Titre : Amidohydrolases

Amidohydrolases : Questions médicales fréquentes

Termes MeSH sélectionnés :

Logistic Models
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Amidohydrolases : Questions médicales les plus fréquentes", "headline": "Amidohydrolases : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Amidohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-19", "dateModified": "2025-03-16", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Amidohydrolases" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Hydrolases", "url": "https://questionsmedicales.fr/mesh/D006867", "about": { "@type": "MedicalCondition", "name": "Hydrolases", "code": { "@type": "MedicalCode", "code": "D006867", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "N-acetylmuramoyl-l-alanine amidase", "alternateName": "N-Acetylmuramoyl-L-alanine Amidase", "url": "https://questionsmedicales.fr/mesh/D009238", "about": { "@type": "MedicalCondition", "name": "N-acetylmuramoyl-l-alanine amidase", "code": { "@type": "MedicalCode", "code": "D009238", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.030" } } }, { "@type": "MedicalWebPage", "name": "Allophanate hydrolase", "alternateName": "Allophanate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D000492", "about": { "@type": "MedicalCondition", "name": "Allophanate hydrolase", "code": { "@type": "MedicalCode", "code": "D000492", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.060" } } }, { "@type": "MedicalWebPage", "name": "Formamidase", "alternateName": "Arylformamidase", "url": "https://questionsmedicales.fr/mesh/D005558", "about": { "@type": "MedicalCondition", "name": "Formamidase", "code": { "@type": "MedicalCode", "code": "D005558", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.100" } } }, { "@type": "MedicalWebPage", "name": "Asparaginase", "alternateName": "Asparaginase", "url": "https://questionsmedicales.fr/mesh/D001215", "about": { "@type": "MedicalCondition", "name": "Asparaginase", "code": { "@type": "MedicalCode", "code": "D001215", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.116" } } }, { "@type": "MedicalWebPage", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "alternateName": "Aspartylglucosylaminase", "url": "https://questionsmedicales.fr/mesh/D001227", "about": { "@type": "MedicalCondition", "name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase", "code": { "@type": "MedicalCode", "code": "D001227", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.125" } } }, { "@type": "MedicalWebPage", "name": "bêta-Lactamases", "alternateName": "beta-Lactamases", "url": "https://questionsmedicales.fr/mesh/D001618", "about": { "@type": "MedicalCondition", "name": "bêta-Lactamases", "code": { "@type": "MedicalCode", "code": "D001618", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Cephalosporinase", "alternateName": "Cephalosporinase", "url": "https://questionsmedicales.fr/mesh/D002510", "about": { "@type": "MedicalCondition", "name": "Cephalosporinase", "code": { "@type": "MedicalCode", "code": "D002510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.229" } } }, { "@type": "MedicalWebPage", "name": "Penicillinase", "alternateName": "Penicillinase", "url": "https://questionsmedicales.fr/mesh/D010405", "about": { "@type": "MedicalCondition", "name": "Penicillinase", "code": { "@type": "MedicalCode", "code": "D010405", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.180.697" } } } ] }, { "@type": "MedicalWebPage", "name": "Biotinidase", "alternateName": "Biotinidase", "url": "https://questionsmedicales.fr/mesh/D043523", "about": { "@type": "MedicalCondition", "name": "Biotinidase", "code": { "@type": "MedicalCode", "code": "D043523", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.200" } } }, { "@type": "MedicalWebPage", "name": "Ceramidases", "alternateName": "Ceramidases", "url": "https://questionsmedicales.fr/mesh/D055572", "about": { "@type": "MedicalCondition", "name": "Ceramidases", "code": { "@type": "MedicalCode", "code": "D055572", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Acid Ceramidase", "alternateName": "Acid Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055573", "about": { "@type": "MedicalCondition", "name": "Acid Ceramidase", "code": { "@type": "MedicalCode", "code": "D055573", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.100" } } }, { "@type": "MedicalWebPage", "name": "Alkaline Ceramidase", "alternateName": "Alkaline Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055574", "about": { "@type": "MedicalCondition", "name": "Alkaline Ceramidase", "code": { "@type": "MedicalCode", "code": "D055574", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.300" } } }, { "@type": "MedicalWebPage", "name": "Neutral Ceramidase", "alternateName": "Neutral Ceramidase", "url": "https://questionsmedicales.fr/mesh/D055576", "about": { "@type": "MedicalCondition", "name": "Neutral Ceramidase", "code": { "@type": "MedicalCode", "code": "D055576", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.250.650" } } } ] }, { "@type": "MedicalWebPage", "name": "Dihydro-orotase", "alternateName": "Dihydroorotase", "url": "https://questionsmedicales.fr/mesh/D004080", "about": { "@type": "MedicalCondition", "name": "Dihydro-orotase", "code": { "@type": "MedicalCode", "code": "D004080", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.280" } } }, { "@type": "MedicalWebPage", "name": "Glutaminase", "alternateName": "Glutaminase", "url": "https://questionsmedicales.fr/mesh/D005972", "about": { "@type": "MedicalCondition", "name": "Glutaminase", "code": { "@type": "MedicalCode", "code": "D005972", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.483" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylases", "alternateName": "Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D006655", "about": { "@type": "MedicalCondition", "name": "Histone deacetylases", "code": { "@type": "MedicalCode", "code": "D006655", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Group III Histone Deacetylases", "alternateName": "Group III Histone Deacetylases", "url": "https://questionsmedicales.fr/mesh/D056545", "about": { "@type": "MedicalCondition", "name": "Group III Histone Deacetylases", "code": { "@type": "MedicalCode", "code": "D056545", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.200" } } }, { "@type": "MedicalWebPage", "name": "Histone deacetylase 6", "alternateName": "Histone Deacetylase 6", "url": "https://questionsmedicales.fr/mesh/D000073864", "about": { "@type": "MedicalCondition", "name": "Histone deacetylase 6", "code": { "@type": "MedicalCode", "code": "D000073864", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.520.350" } } } ] }, { "@type": "MedicalWebPage", "name": "Nicotinamidase", "alternateName": "Nicotinamidase", "url": "https://questionsmedicales.fr/mesh/D009535", "about": { "@type": "MedicalCondition", "name": "Nicotinamidase", "code": { "@type": "MedicalCode", "code": "D009535", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.610" } } }, { "@type": "MedicalWebPage", "name": "Penicillin amidase", "alternateName": "Penicillin Amidase", "url": "https://questionsmedicales.fr/mesh/D010399", "about": { "@type": "MedicalCondition", "name": "Penicillin amidase", "code": { "@type": "MedicalCode", "code": "D010399", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.690" } } }, { "@type": "MedicalWebPage", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "alternateName": "Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase", "url": "https://questionsmedicales.fr/mesh/D043524", "about": { "@type": "MedicalCondition", "name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase", "code": { "@type": "MedicalCode", "code": "D043524", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.725" } } }, { "@type": "MedicalWebPage", "name": "5-Oxoprolinase(ATP-hydrolysing)", "alternateName": "Pyroglutamate Hydrolase", "url": "https://questionsmedicales.fr/mesh/D011752", "about": { "@type": "MedicalCondition", "name": "5-Oxoprolinase(ATP-hydrolysing)", "code": { "@type": "MedicalCode", "code": "D011752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.760" } } }, { "@type": "MedicalWebPage", "name": "Urease", "alternateName": "Urease", "url": "https://questionsmedicales.fr/mesh/D014510", "about": { "@type": "MedicalCondition", "name": "Urease", "code": { "@type": "MedicalCode", "code": "D014510", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D08.811.277.087.902" } } } ], "about": { "@type": "MedicalCondition", "name": "Amidohydrolases", "alternateName": "Amidohydrolases", "code": { "@type": "MedicalCode", "code": "D000581", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Rolandas Meškys", "url": "https://questionsmedicales.fr/author/Rolandas%20Me%C5%A1kys", "affiliation": { "@type": "Organization", "name": "Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania." } }, { "@type": "Person", "name": "Yumei Hu", "url": "https://questionsmedicales.fr/author/Yumei%20Hu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Longhai Dai", "url": "https://questionsmedicales.fr/author/Longhai%20Dai", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China." } }, { "@type": "Person", "name": "Du Niu", "url": "https://questionsmedicales.fr/author/Du%20Niu", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } }, { "@type": "Person", "name": "Zhenzhen Xie", "url": "https://questionsmedicales.fr/author/Zhenzhen%20Xie", "affiliation": { "@type": "Organization", "name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "A novel multivariate logistic model for predicting risk factors of failed treatment with carbapenem-resistant", "datePublished": "2024-05-09", "url": "https://questionsmedicales.fr/article/38784576", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fpubh.2024.1385118" } }, { "@type": "ScholarlyArticle", "name": "Application of multivariate binary logistic regression grouped outlier statistics and geospatial logistic model to identify villages having unusual health-seeking habits for childhood malaria in Malawi.", "datePublished": "2024-08-16", "url": "https://questionsmedicales.fr/article/39152481", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12936-024-05070-2" } }, { "@type": "ScholarlyArticle", "name": "Forecasting of coronavirus active cases by utilizing logistic growth model and fuzzy time series techniques.", "datePublished": "2024-08-04", "url": "https://questionsmedicales.fr/article/39098877", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-67161-z" } }, { "@type": "ScholarlyArticle", "name": "Ultrasound Radiomics-Based Logistic Regression Model to Differentiate Between Benign and Malignant Breast Nodules.", "datePublished": "2022-08-16", "url": "https://questionsmedicales.fr/article/36149670", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/jum.16078" } }, { "@type": "ScholarlyArticle", "name": "Construction of Enterprise Financial Early Warning Model Based on Logistic Regression and BP Neural Network.", "datePublished": "2022-05-24", "url": "https://questionsmedicales.fr/article/35655497", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/2614226" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Enzymes et coenzymes", "item": "https://questionsmedicales.fr/mesh/D045762" }, { "@type": "ListItem", "position": 3, "name": "Enzymes", "item": "https://questionsmedicales.fr/mesh/D004798" }, { "@type": "ListItem", "position": 4, "name": "Hydrolases", "item": "https://questionsmedicales.fr/mesh/D006867" }, { "@type": "ListItem", "position": 5, "name": "Amidohydrolases", "item": "https://questionsmedicales.fr/mesh/D000581" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Amidohydrolases - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Amidohydrolases", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-07", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Amidohydrolases", "description": "Comment diagnostiquer une déficience en amidohydrolases ?\nQuels tests sanguins sont utilisés pour évaluer les amidohydrolases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème d'amidohydrolases ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=3#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Amidohydrolases", "description": "Quels sont les symptômes d'une déficience en amidohydrolases ?\nLes troubles métaboliques sont-ils liés aux amidohydrolases ?\nY a-t-il des signes cutanés associés aux troubles enzymatiques ?\nLes symptômes varient-ils selon le type d'amidohydrolase ?\nLes symptômes sont-ils immédiats ou progressifs ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=3#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Amidohydrolases", "description": "Peut-on prévenir les troubles liés aux amidohydrolases ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nUne alimentation équilibrée peut-elle prévenir ces troubles ?\nLes vaccinations ont-elles un rôle dans la prévention ?\nL'éducation sur les maladies héréditaires est-elle importante ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=3#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Amidohydrolases", "description": "Quels traitements existent pour les déficiences en amidohydrolases ?\nLes médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?\nLa thérapie génique est-elle une option pour ces troubles ?\nLes changements alimentaires peuvent-ils améliorer les symptômes ?\nY a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=3#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Amidohydrolases", "description": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?\nLes troubles d'amidohydrolases peuvent-ils affecter la croissance ?\nY a-t-il des risques de maladies auto-immunes ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=3#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Amidohydrolases", "description": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?\nL'âge influence-t-il le risque de troubles enzymatiques ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe mode de vie peut-il influencer le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?", "url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=Logistic+Models&page=3#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une déficience en amidohydrolases ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués." } }, { "@type": "Question", "name": "Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases." } }, { "@type": "Question", "name": "Les biopsies sont-elles nécessaires pour le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème d'amidohydrolases ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique." } }, { "@type": "Question", "name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une déficience en amidohydrolases ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs." } }, { "@type": "Question", "name": "Les troubles métaboliques sont-ils liés aux amidohydrolases ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques." } }, { "@type": "Question", "name": "Y a-t-il des signes cutanés associés aux troubles enzymatiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le type d'amidohydrolase ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée." } }, { "@type": "Question", "name": "Les symptômes sont-ils immédiats ou progressifs ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience." } }, { "@type": "Question", "name": "Peut-on prévenir les troubles liés aux amidohydrolases ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques." } }, { "@type": "Question", "name": "Les tests génétiques peuvent-ils aider à la prévention ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques." } }, { "@type": "Question", "name": "Une alimentation équilibrée peut-elle prévenir ces troubles ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention." } }, { "@type": "Question", "name": "Les vaccinations ont-elles un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques." } }, { "@type": "Question", "name": "L'éducation sur les maladies héréditaires est-elle importante ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés." } }, { "@type": "Question", "name": "Quels traitements existent pour les déficiences en amidohydrolases ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques." } }, { "@type": "Question", "name": "Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie." } }, { "@type": "Question", "name": "La thérapie génique est-elle une option pour ces troubles ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles." } }, { "@type": "Question", "name": "Les changements alimentaires peuvent-ils améliorer les symptômes ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques." } }, { "@type": "Question", "name": "Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications digestives, métaboliques et neurologiques peuvent se développer." } }, { "@type": "Question", "name": "Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants." } }, { "@type": "Question", "name": "Y a-t-il des risques de maladies auto-immunes ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications potentielles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés." } }, { "@type": "Question", "name": "L'âge influence-t-il le risque de troubles enzymatiques ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques." } }, { "@type": "Question", "name": "Les maladies métaboliques augmentent-elles le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases." } }, { "@type": "Question", "name": "Le mode de vie peut-il influencer le risque ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque." } }, { "@type": "Question", "name": "Les facteurs environnementaux jouent-ils un rôle ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases." } } ] } ] }

Sous-catégories

23 au total
└─

N-acetylmuramoyl-l-alanine amidase

N-Acetylmuramoyl-L-alanine Amidase D009238 - D08.811.277.087.030
└─

Allophanate hydrolase

Allophanate Hydrolase D000492 - D08.811.277.087.060
└─

Formamidase

Arylformamidase D005558 - D08.811.277.087.100
└─

Asparaginase

Asparaginase D001215 - D08.811.277.087.116
└─

N4-(beta-N-acetylglucosaminyl)-L-asparaginase

Aspartylglucosylaminase D001227 - D08.811.277.087.125
└─

bêta-Lactamases

beta-Lactamases D001618 - D08.811.277.087.180
└─

Biotinidase

Biotinidase D043523 - D08.811.277.087.200
└─

Ceramidases

Ceramidases D055572 - D08.811.277.087.250
└─

Dihydro-orotase

Dihydroorotase D004080 - D08.811.277.087.280
└─

Glutaminase

Glutaminase D005972 - D08.811.277.087.483
└─

Histone deacetylases

Histone Deacetylases D006655 - D08.811.277.087.520
└─

Nicotinamidase

Nicotinamidase D009535 - D08.811.277.087.610
└─

Penicillin amidase

Penicillin Amidase D010399 - D08.811.277.087.690
└─

Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase

Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase D043524 - D08.811.277.087.725
└─

5-Oxoprolinase(ATP-hydrolysing)

Pyroglutamate Hydrolase D011752 - D08.811.277.087.760
└─

Urease

Urease D014510 - D08.811.277.087.902
└─└─

Cephalosporinase

Cephalosporinase D002510 - D08.811.277.087.180.229
└─└─

Penicillinase

Penicillinase D010405 - D08.811.277.087.180.697
└─└─

Acid Ceramidase

Acid Ceramidase D055573 - D08.811.277.087.250.100
└─└─

Alkaline Ceramidase

Alkaline Ceramidase D055574 - D08.811.277.087.250.300
└─└─

Neutral Ceramidase

Neutral Ceramidase D055576 - D08.811.277.087.250.650
└─└─

Group III Histone Deacetylases

Group III Histone Deacetylases D056545 - D08.811.277.087.520.200
└─└─

Histone deacetylase 6

Histone Deacetylase 6 D000073864 - D08.811.277.087.520.350

Sources (10000 au total)

A novel multivariate logistic model for predicting risk factors of failed treatment with carbapenem-resistant

This study aimed to explore the risk factors for failed treatment of carbapenem-resistant... A total of 189 CRAB-VAP patients were included in the safety analysis set from two Grade 3 A national-level hospitals between 1 January 2022 and 31 December 2022. The risk factors for failed treatment... Of the 189 patients, 106 (56.1%) patients were in the successful treatment group, and 83 (43.9%) patients were in the failed treatment group. The multivariate logistic model analysis showed that age (... Age, hypoproteinemia, daily dose, medication within 14 days prior to surgical intervention, and microbial clearance are all significant risk factors for failed treatment with CRAB-VAP, with the nomogr...

Application of multivariate binary logistic regression grouped outlier statistics and geospatial logistic model to identify villages having unusual health-seeking habits for childhood malaria in Malawi.

Early diagnosis and prompt treatment of malaria in young children are crucial for preventing the serious stages of the disease. If delayed treatment-seeking habits are observed in certain areas, targe... This study applied multivariate binary logistic regression model diagnostics and geospatial logistic model to identify traditional authorities in Malawi where caregivers have unusual health-seeking be... Both models showed significant variability in treatment-seeking habits of caregivers between villages. The mixed-effects logit model residual identified Vuso Jere, Kampingo Sibande, Ngabu, and Dzoole ... These findings suggest that using a combination of multivariate regression model residuals and geospatial statistics can help in identifying communities with distinct treatment-seeking patterns for ch...

Ultrasound Radiomics-Based Logistic Regression Model to Differentiate Between Benign and Malignant Breast Nodules.

To explore the potential value of ultrasound radiomics in differentiating between benign and malignant breast nodules by extracting the radiomic features of two-dimensional (2D) grayscale ultrasound i... The clinical and ultrasound data of 1000 female patients (500 pathologically benign patients, 500 pathologically malignant patients) who underwent breast ultrasound examinations at our hospital were r... Eight ultrasound radiomic features were selected to establish the model. The AUC values of the model were 0.979 and 0.977 in the training and validation sets, respectively (P = .0029), indicating good... The proposed logistic regression model based on 2D grayscale ultrasound images could facilitate differential diagnosis of benign and malignant breast nodules. The model, which was constructed using ul...

Poor handling of continuous predictors in clinical prediction models using logistic regression: a systematic review.

When developing a clinical prediction model, assuming a linear relationship between the continuous predictors and outcome is not recommended. Incorrect specification of the functional form of continuo... We searched PubMed for clinical prediction model studies developing a logistic regression model for a binary outcome, published between July 01, 2020, and July 30, 2020.... In total, 118 studies were included in the review (18 studies (15%) assessed the linearity assumption or used methods to handle nonlinearity, and 100 studies (85%) did not). Transformation and splines... Though widely recommended not to categorize continuous predictors or assume a linear relationship between outcome and continuous predictors, most studies categorize continuous predictors, few studies ...

Development of crash prediction models by assessing the role of perpetrators and victims: a comparison of ANN & logistic model using historical crash data.

Road traffic injuries cost countries 3% of their annual GDP. In developing countries like India, every year around 150,000 people die on roads. The type of vehicles involved in a crash contribute majo...

Random forest model can predict the prognosis of hospital-acquired Klebsiella pneumoniae infection as well as traditional logistic regression model.

To explore if random forest (RF) model can predict the prognosis of hospital-acquired Klebsiella pneumoniae infection as well as traditional logistic regression(LR) model.... A total of 254 cases of hospital-acquired Klebsiella pneumoniae infection in a tertiary hospital in Beijing from January 2016 to December 2020 were retrospectively collected. Appropriate influencing f... The prediction accuracy of the LR model was 87.0%, the true positive rate of the LR model was 94.7%; the false negative rate of the LR model was 5.3%; the false positive rate of the LR model was 35%; ... The RF model has higher specificity, sensitivity, and accuracy for the prognostic prediction of hospital-acquired Klebsiella pneumoniae infection than the LR model and has greater clinical application...